Enochian BioSciences to Present to Investors at 22nd Annual H.C. Wainwright Global Investment Conference
LOS ANGELES, Sept. 10, 2020 (GLOBE NEWSWIRE) — (NASDAQ: ENOB) − Enochian BioSciences, a company focused on gene-modified cellular and […]
Albireo Prices Public Offering of 4,000,000 Shares of Common Stock
BOSTON, Sept. 09, 2020 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing […]
LSI Industries Inc. to Present During H.C. Wainwright & Company’s Virtual Investment Conference
CINCINNATI, Sept. 09, 2020 (GLOBE NEWSWIRE) — LSI Industries Inc. (NASDAQ: LYTS, or the “Company”) a leading U.S. based manufacturer […]
Plus Therapeutics, Inc. to Present at the 22nd H. C. Wainwright Annual Global Investor Conference on September 15, 2020
AUSTIN, Texas, Sept. 09, 2020 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), today announced that it has been […]
BJ’s Restaurants, Inc. to Participate at CL King’s 18th Annual Best Ideas Conference 2020 Virtual Event
HUNTINGTON BEACH, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) — BJ’s Restaurants, Inc. (NASDAQ: BJRI) announced today that Chief Executive Officer, […]
Vaxcyte to Present at 2020 Cantor Virtual Global Healthcare Conference
FOSTER CITY, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) — Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking […]
Greenlight Capital Re, Ltd. Announces Leadership Changes
Simon Burton – Chief Executive Officer and Chief Underwriting OfficerNeil Greenspan – Chief Financial OfficerFaramarz Romer – Chief Accounting Officer […]
Sarepta Therapeutics Provides Program Update for SRP-9001, its Investigational Gene Therapy for the Treatment of Duchenne Muscular Dystrophy
CAMBRIDGE, Mass., Sept. 09, 2020 (GLOBE NEWSWIRE) — Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare […]
Streamline Health® Reports Second Quarter 2020 Revenues of $2.9 million; ($1.1 million) Net Loss; Adjusted EBITDA ($0.4 million)
Total First Half Fiscal 2020 Revenues of $5.7 million; $2.5 million Net Income; Adjusted EBITDA ($1.0 million)Atlanta, GA, Sept. 09, […]
Spero Therapeutics Announces Proposed Public Offering
CAMBRIDGE, Mass., Sept. 09, 2020 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on […]
